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BOTH 9,10-dimethyl-1,2-benzanthracene (DMBA) and urethane induce a wide
variety of tumours when injected subcutaneously into newborn mice and rats
(Pietra, Spencer and Shubik, 1959; Pietra, Rappaport and Shubik, 1961; Roe,
Rowson and Salaman, 1961; Fiore-Donati et al., 1961; Toth and Shubik, 1963;
Howell, 1963; Roe, Millican and Shubik, 1963). A large proportion ofhamsters
injected within 4 hours of birth with 100 ,ug. DMBA developed melanotic
tumours of the skin and subcutaneous sarcomas (Lee, Toth and Shubik, 1963).
In comparison with controls there was a slight acceleration in the appearance of
malignant lymphomas.
Subcutaneous injection ofDMBA into adult hamsters induced sarcomas, while
application ofDMBA to the skin led to the development ofdermal melanocytomas
(Crabb, 1946; Della Porta et al., 1956). Urethane administered in the drinking
water induced melanotic skin tumours, papillomas and carcinomas of the foresto-
mach, hepatomas, mammary tumours and haemangiosarcomas (Toth, Tomatis
and Shubik, 1961).
The experiments reported in the present paper were begun before the publica-
tion of the report by Lee et al. (1963): the new results confirm and extend their
observations.
MATERIALS AND METHODS
Hamsters.-Litters of golden Syrian hamsters were taken from a colony bred
in this Institute since 1947. The sucklings were housed with their mothers until
they were 5 weeks old, when they were weaned. The sexes were separated by
partitions in large metal cages. The hamsters received a cubed diet (Diet 86,
Messrs. Dixon and Sons, Ware, Herts.) and tap water ad libitum.
Chemical Agents.-9,10-dimethyl-1,2-benzanthracene was obtained from Roche
Products Ltd., and suspended in 1 per cent aqueous gelatine, using the method of
Pietra et al. (1959). Urethane (from Hopkin and Williams Ltd.) was dissolved
in 1 per cent aqueous gelatine.
EXPERIMENTAL
The litters were randomly divided into four groups. Hamsters in Group 1
received a single subcutaneous injection in the scapular region of 50 ,tg. DMBA
in 0*02 ml. aqueous gelatine during the first 24 hours after birth. Group 2 wasINDUCTION OF TUMOURS IN HAMSTERS
similarly treated with 150 ,tg. urethane in aqueous gelatine and Group 3 received
aqueous gelatine alone. Group 4 was an untreated control group.
Maternal cannibalism and " wet-tail ", an intestinal infection caused by an
unidentified pathogen, led to high mortality before weaning. Of 127 hamsters
injected with DMBA, only 39 survived until they were 5 weeks old. Thereafter
the animals were examined at weekly intervals and the occurrence and growth
of cutaneous and subcutaneous tumours were recorded. Operative removal of
subcutaneous tumours was attempted under ether anaesthesia. All except one
tumour showed obvious invasion of the body wall, making complete removal
impossible. The remaining tumour recurred 4 weeks after its apparently success-
ful eradication. Two hamsters died as a result of the operation and the rest
were killed when their tumours had grown to a size of 15-20 mm. Complete
autopsies were carried out on hamsters which died during the experiment and
on those which were killed when it was terminated at 60 weeks. All melanotic
skin tumours, a proportion of the melanotic spots which arose on the skin and
all other possibly neoplastic lesions were taken for microscopic examination.
RESULTS
Survival and tumour incidence are shown in Table I. A dose of 50 ,tg. DMBA
induced melanotic skin tumours and injection-site sarcomas in males and females
(Group 1). Seven ofthe eight subcutaneous injection-site tumours were invasive
pleomorphic sarcomas; the remaining tumour was a myxosarcoma of low grade
malignancy. No tumours were seen in the hamsters treated with urethane
(Group 2). A mammaryfibroadenocarcinoma arose in one ofthe aqueousgelatine-
treated controls (Group 3), but no tumours were seen in the untreated controls
(Group 4).
DERMAL MELANOTIC TUMOURS
Only spheroid or ovoid lesions larger than 2 mm. in average diameter have
been included in the numbers shown in Table I. Many hamsters in Group 1
also had melanotic spots smaller than 2 mm. in diameter on the skin. Some of
these probably represented the early stages of larger lesions. In six hamsters
the tumours were multiple. The majority were situated on the dorsal skin. In
ten hamsters, one or more melanotic tumours developed on the margins of the
eyelids (Fig. 1) which are normally heavily pigmented. One hamster had a
tumour on its snout. The dorsally situated tumours were as frequent in the lum-
ber as in the scapular region. None arose from the male " flank organ" (costo-
vertebral spot) (Ghadially and Barker, 1960; Oberman and Riviere, 1962).
In one hamster with a pigmented tumour of the skin there was what appeared to
be a metastatic deposit in the lung.
A histopathological study of the cutaneous lesions suggested that they arose
as aggregates of melanin-containing dendritic or thin spindle cells around the
pilo-sebaceous follicles. The follicles are later engulfed by the proliferation of
the pigment cells (Fig. 2). The larger melanotic tumours are spheroid or ovoid
and flattened on the deep surface (Fig. 1). There was no involvement of the
dermo-epidermal junction in any ofthe lesions. When the sections were bleached
it could be seen that the tumour masses consisted mainly of large polyhedral
cells (Fig. 3 and 4). Multinucleate cells were common in some of the lesions.
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There was a variable reticulin and collagenous interstitium, and nests of smaller
unpigmented cells were seen in some areas (Fig. 3). All of these tumours were
regarded as benign. The large cells are probably storage cells, i.e., melanophages.
The tumours were too heavily pigmented to perform dopa oxidase reactions.
Two tumours differed histologically from the majority in that they consisted
of two types of cell, polyhedral melanophages and spindle cells with large pleo-
morphic vesicular nuclei, in something approaching equal proportions (Fig. 5
and 6). The second type of cell was poorly pigmented or completely amelanotic.
Occasional mitoses were seen in the spindle cells (Fig. 7) but none in the poly-
hedral cells. It was in one of the hamsters with a tumour of this type that a
metastasis was found in the lung. Curiously the metastatic deposit appeared to
consist almost solely ofpigmented cells ofthepolyhedral type. It was considered
unlikely that the lung lesion was a primary tumour because no similar lesions
occurred in any of the other test animals nor has their induction been reported
by other workers.
DISCUSSION
In general the results were similar to those reported by Lee, Toth and Shubik
(1963). Using a 100 ,ug. dose of DMBA in tricaprylin, they found that 91.3 per
cent offemale and 88.2 per cent ofmale hamsters developed melanomas, and 78-2
per cent females and 80-2 per cent males developed subcutaneous sarcomas.
These percentages are higher than those reported, probably because of the differ-
ence in dose of DMBA, but the vehicle may also have been important, especially
in relation to the induction of sarcomas at the injection site.
The failure in the present experiment to induce tumours by the injection of
150 ,g. urethane into newborn hamsters is probably attributable to the fact that
the dose was too low. In the experiments of Toth, Tomatis and Shubik (1961)
in which hamsters developed melanotic tumours in response to urethane, the
doses were much larger: the animals received urethane in their drinking water
for 42 weeks. In newborn mice, 100 ,ug. urethane induced malignant lymphomas
and lung adenomas, but 40 ,g. had no carcinogenic effect (Pietra, Rappaport and
Shubik, 1961). A further test of urethane in hamsters, at a higher dose level, is
indicated.
Macroscopically and cytologically the melanotic tumours obtained by injecting
newborn hamsters with DMBA (Lee et al., 1963) were similar to those induced by
skin applications of DMBA in adults (Della Porta et al., 1956). The majority of
tumours were benign and were considered by those authors to be dermal melano-
cytomas. Amelanotic and hypomelanotic melanomas have been induced in
Syrian white hamsters by application ofDMBA to the skin (Illman and Ghadially,
1960; Rappaport, Pietra and Shubik, 1961). In such lesions there is no evidence
ofjunctional activity like that seen in the human naevus (Ghadially and Barker,
1960), though Fortner and Allen (1958) observed junctional activity in a spon-
taneous malignant melanoma of the Syrian hamster. Nakai and Rappaport
(1963) found that the aggregates ofmelanocytes in DMBA-induced tumours were
separated from the dermo-epidermal junction by a zone of uninvolved dermal
connective tissue. According to Ghadially and Barker (1960) the earliest tumours
consistofaggregatesofmelanocytes surrounding pilo-sebaceous units inthe dermis.
With increasing size and anaplasia, large clear cells are often produced.
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The two unusual lesions seen in the present experiment (Fig. 5, 6 and 7)
suggest that malignant as well as benign melanotic tumours may occasionally be
induced by the injection of DMBA into newborn hamsters. The fact that these
apparently malignant tumours consisted of two types of cell in more or less equal
proportions is especially interesting. So far there has been no explanation of the
accumulation of melanin and of melanocytes in the typical benign lesion, particu-
larly as mitotic figures are not seen in the melanocytes. In the light ofthe present
results it seems reasonable to postulate that some of the inconspicuous non-
pigmented cells are responsible for melanin production, and that a neoplastic
change in these cells, rather than in the more conspicuous melanophagic cells,
is the basis of the malignant behaviour of lesions. The metastasis of melanin-
producing cells to a distant site is followed by the local recruitment of melano-
phagic cells. This, we feel, is probably the explanation of the difference in histo-
logical appearances between the primary and the lung metastasis in the case
reported in the present paper: the metastatic cells, being particularly abundant
melanin producers, quickly became obscured by melanophagic cells so that the
metastasis appeared different from the primary tumour.
SUMMARY
Neonatal injection of 50 ,ug. DMBA in aqueous gelatine induced injection-site
sarcomas in 9 per cent of male and 25 per cent of female hamsters, and melanotic
tumours in 63-6 per cent males and 35-7 per cent females. The melanotic tumours
arose in the dermis of the dorsal skin and in the margins of the eyelids. The
majority of the tumours were benign, but in one hamster there was what was
regarded as a metastatic deposit in the lung. No tumours were seen in hamsters
EXPLANATION OF PLATES
All lesions were seen in hamsters injected at birth with50 ,ig. DMBA.
FIG.1.-Typical melanotic lesion in eyelid of9 hamster. The lesion appeared 9 months
after injection and the animal was killed at one year. Note collection of melanocytes in
relation to neighbouring follicles. H. & E. x 38.
FIG. 2.-Higher power view of typical lesion from eyelid of S hamster. The lesion appeared
4 months after injection and the animal was killed one month later. Note the outlining
of the pilosebaceous follicles by melanin-containing cells. H. & E. x 100.
FIG. 3.-Bleached preparation of a dermal lesion which appeared on the dorsum of a CT hamster
6 months after injection. The animal died at 9 months. The lesion consists mainly of
large polyhedral melanin-containing cells with occasional nests of smaller cells. H. & E.
bleached x 100.
FIG. 4. Higher power view of lesion shown in Fig. 3. The small cells are less apparent in
the area depicted. In some of the cells it is clear that the nucleus occupies a peripheral
position. H. & E. bleached x 525.
FIG. 5. Melanotic lesion from scapular region of 9 month-old Y hamster. The lesion appeared
during the 6th month and consists of a mixture of pale-staining spindle cells and moderately
heavily pigmented melanin-containing cells. The intact epidermis may be seen at the
right of the picture. H. & E. x 100.
FIG. 6.-Higher power view of tumour depicted in Fig. 5 from an area where the demarcation
between the two types of cell is indistinct. Note metaphase near middle of picture.
H. & E. x 225.
FIG. 7. Part of pigmented tumour of eyelid of 8-month-old 9 hamster. The lesion which
appeared during the 4th month consists of cells with large vesicular nuclei and amelanotic
cytoplasm. cf. Fig. 4, which is at the same magnification. A deposit regarded as a meta-
stases of this tumour was present in the lung. H. & E. x 525.
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injected at birth with 150 ,ug. urethane. A mammary fibroadenocarcinoma arose
in one animal injected with aqueous gelatine only. No tumours arose in untreated
controls.
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